Skip to content

Clinical trials

Phase 2 Intermittent Claudication trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Intermittent Claudication Phase: Phase 2 Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20052
20063
20071
20081
20092
20101
20123
20132
20141
20151
20161
20171
20181
20221
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Unknown status5
Recruiting2
Not yet recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Northwestern University2
Novartis Pharmaceuticals2
Sanofi2
Angiogenix1
BioMarin Pharmaceutical1
Chinese University of Hong Kong1
Cytokinetics1
Emory University1
Flanders Medical Research Program1
FlowMedic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Intermittent Claudication27
Peripheral Arterial Disease21
Peripheral Vascular Diseases7
Arterial Occlusive Diseases2
Atherosclerosis2
Mobility Limitation2
Arteriosclerosis Obliterans1
Chronic Limb-Threatening Ischemia1
Disease1
Vascular Diseases1

Trials

Showing 76 to 27 of 27. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.